Community-Based Provision of Direct-Acting Antiviral Therapy for Hepatitis C: Study Protocol and Challenges of a Randomized Controlled Trial

Trials - United Kingdom
doi 10.1186/s13063-018-2768-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Digestive Diseases and Sciences
PhysiologyGastroenterology
2011English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer
Cancer ResearchOncology
2015English

Systematic Review: Current Concepts and Challenges for the Direct-Acting Antiviral Era in Hepatitis C Cirrhosis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

A Primary Care-Based Collaborative Hepatitis C Clinic: Clinical Structure and Virologic Outcomes With Direct Acting Antiviral Therapy

Open Medicine Journal
2016English

Development of Proteinuria and Focal Segmental Glomerulosclerosis During Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection

Hepatology
MedicineHepatology
2017English

Challenges and Innovations in a Community-Based Participatory Randomized Controlled Trial

Health Education and Behavior
EnvironmentalArtsOccupational HealthPublic HealthHumanities
2016English

Daclatasvir/Asunaprevir Based Direct-Acting Antiviral Therapy Ameliorate Hepatitis C Virus-Associated Cryoglobulinemic Membranoproliferative Glomerulonephritis: A Case Report

BMC Nephrology
Nephrology
2017English

Concerns About Direct-Acting Antiviral Agents for Hepatitis C—Cause for Reassurance

JAMA network open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy